The US is set to introduce a new weight loss pill in January 2026. The US Food and Drug Administration (FDA) has approved the pill version of Wegovy, a weight loss drug made by the Danish pharmaceutical company Novo Nordisk.
Reuters
This is the first pill of its kind to get FDA approval, marking a significant change in the world of weight loss treatments. Novo Nordisk said the pill is a convenient option compared to the injectable version of Wegovy and offers similar results. Wegovy was already approved by the FDA for weight loss.
Here are some key facts about the pill: In clinical trials, the Wegovy pill helped people lose an average of 16.6% of their body weight.
About a third of the nearly 1,300 people in the study lost 20% or more of their weight. The pill is expected to be available in the US in early January 2026.